BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed
BBOT Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for BBOT stock have an average target of 25.11, with a low estimate of 18 and a high estimate of 41. The average target predicts an increase of 239.32% from the current stock price of 7.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BBOT stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Mazahir Alimohamed Oppenheimer No rating | Oppenheimer | Buy Maintains $22 | Buy | Maintains | $22 | +197.30% | Jun 22, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $23 | Buy | Maintains | $23 | +210.81% | Jun 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +183.78% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $18 | Buy | Maintains | $18 | +143.24% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $25 | Buy | Maintains | $25 | +237.84% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.23
from -4.30
EPS Next Year
-2.13
from -2.23
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.72 | -1.61 | |
| Avg | -2.23 | -2.13 | |
| Low | -2.72 | -2.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.